| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
40,081 |
39,540 |
$4.31M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
54,105 |
53,598 |
$4.12M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
18,994 |
18,992 |
$1.81M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
11,876 |
11,876 |
$1.68M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
31,993 |
31,827 |
$920K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16,971 |
16,871 |
$619K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14,146 |
14,075 |
$582K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
32,829 |
32,681 |
$479K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
7,753 |
7,689 |
$385K |
| 87807 |
|
699 |
694 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
327 |
321 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
73 |
73 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
48 |
48 |
$55.77 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
28 |
28 |
$49.98 |
| 81003 |
|
25 |
25 |
$48.11 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
17 |
17 |
$29.61 |